S 5571
119th Congress • 2025-2027 (Current)

A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.


S 5571
Sep 28, 2026
Read twice and referred to the Committee on Finance.